Getwell Oncology Profile
Key Indicators
- Authorised Capital ₹ 2.50 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 11 Months
- Last Filing with ROC 31 Mar 2023
- Revenue Growth -99.08%
- Profit Growth 59.31%
- Ebitda 82.27%
- Net Worth -27.40%
- Total Assets -11.61%
About Getwell Oncology
Getwell Oncology Private Limited (GOPL) is a Private Limited Indian Non-Government Company incorporated in India on 12 March 2010 and has a history of 14 years and 11 months. Its registered office is in East Delhi, Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 2.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Manas Tandon and Mini Tandon serve as directors at the Company.
Company Details
- Location
East Delhi, Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U85191DL2010PTC200011
- Company No.
200011
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
12 Mar 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Getwell Oncology?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Mini Tandon  | Director | 12-Mar-2010 | Current |
| Manas Tandon | Director | 12-Mar-2010 | Current |
Financial Performance of Getwell Oncology.
Getwell Oncology Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 99.08% decrease. The company also saw a substantial improvement in profitability, with a 59.31% increase in profit. The company's net worth observed a substantial decline by a decrease of 27.4%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Getwell Oncology?
Unlock access to Getwell Oncology's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Getwell Pharma India Private LimitedManas Tandon and Mini Tandon are mutual person
Getwell Therapeutics Private LimitedManas Tandon and Mini Tandon are mutual person
- Getwell Research Foundation
Manas Tandon and Mini Tandon are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Getwell Oncology?
Getwell Oncology has a workforce of 11 employees as of Aug 20, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Getwell Oncology, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Getwell Oncology's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
